Evidence map›Paper›PMID 36843683›Full record

ArticleCureus2023

Unilateral Vocal Fold Paralysis and Voice Therapy: Predictors of Long-Term Quality of Life.

Francisco Sousa, Mariline Santos, Sara Azevedo, Ana Pinto, Susana Vaz Freitas, Miguel Coutinho, Cecília Almeida E Sousa, Álvaro Moreira da Silva

Abstract read
In one paragraph

Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Association between disease duration, severity, and treatment outcome of office-based blue laser therapy for benign vocal fold lesions.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Francisco SousaOtolaryngology - Head and Neck Surgery, Centro Hospitalar Universitário do Porto, Porto, PRT.
Mariline SantosOtolaryngology - Head and Neck Surgery, Centro Hospitalar Universitário do Porto, Porto, PRT.
Sara AzevedoOtolaryngology - Head and Neck Surgery, Centro Hospitalar Universitário do Porto, Porto, PRT.
Ana PintoOtolaryngology - Head and Neck Surgery, Centro Hospitalar Universitário do Porto, Porto, PRT.
Susana Vaz FreitasOtolaryngology - Head and Neck Surgery, Centro Hospitalar Universitário do Porto, Porto, PRT.
Miguel CoutinhoOtolaryngology - Head and Neck Surgery, Centro Hospitalar Universitário do Porto, Porto, PRT.
Cecília Almeida E SousaOtolaryngology - Head and Neck Surgery, Centro Hospitalar Universitário do Porto, Porto, PRT.
Álvaro Moreira da SilvaIntensive Care Unit, Centro Hospitalar Universitário do Porto, Porto, PRT.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To date, little is known about the long-term predictors of quality of life (QoL) in unilateral vocal fold paralysis (UVFP). The main objective of this study was to evaluate the predictors of long-term QoL in UVFP patients submitted to voice therapy (VT) exclusively. Data from patients diagnosed with UVFP who followed a VT program between 2013 and 2019 were reviewed. Video laryngoscopy (VL) records were obtained at the beginning and at the end of VT. To assess QoL, Voice Handicap Index 30 (VHI-30) score was assessed in three temporal frames: before voice therapy (pre-VT), at the last VT session (post-VT), and in the present (cur-VHI). A longitudinal analysis was performed regarding the evolution of QoL and the factors influencing QoL through time were analyzed. Seventy-eight percent of patients had iatrogenic UVFP. The mean time of follow-up after VT was 3.942 years (range 6 months-7 years). There was a significant improvement in QoL through all time points (F (2,88)=72.179, p<0.001), with VHI-30 decrease from the baseline pre-VT to post-VT(p<0.001) and from post-VT to cur-VT (p=0.0013). In the iatrogenic UVFP population, patients starting VT earlier showed better long-term QoL (p=0.023). UVFP patients with dysphagia at presentation showed significantly worse QoL in the late follow-up (p=0.016). Hence, iatrogenic UVFP patients beginning VT rapidly may show better QoL in the future. Also, our results suggest that dysphagia at UVFP onset may predict higher morbidity later in life.

Indexed as

dysphagiaquality of lifetimeunilateral vocal fold paralysisvhi-30voice handicap indexvoice therapy

Identifiers

PMID36843683
PMCPMC9945010

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.